Clinical Trial Update: vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC [NA]

View source ↗

Summary

Phase I clinical trial evaluating vGRID SBRT for unresectable or metastatic hepatocellular carcinoma, currently recruiting at University of Kansas Medical Cente…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Liver Cancer | NA | Status: RECRUITING